Elise A. Chong, MD

Adam Kittai, Paul Hampel, Ying Huang, John Allan, Seema Bhat, David Bond, Danielle Brander, John Byrd, Julio Chavez, Elise Chong, Alexey Danilov, Matthew Davids, Kaitlyn Dvorak-Kornaus, Hannah Freedman, Nikita Malakhov, Mathew Matasar, Cecelia Miller, Sarah Miller-Branam, Zulfa Omer, Sameer Parikh, Erin Parry, Kari Rabe, Philipp Raess, Manoj Rai, Joanna Rhodes, Kerry Rogers, Aditi Saha, Jake Schade, Geoffrey Shouse, Stephen Spurgeon, Deborah Stephens, Yucai Wang, Jennifer Woyach, Max Yano Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia , Blood Cancer Journal: 2026

Chong EA, Tomasulo EB, Barta SK. 2026 Update on the Management of Diffuse Large B-Cell Lymphoma , Am J Hematol, 101(4): 2026,832-863

Shan Liu; Puneeth Guruprasad; Ranjani Ramasubramanian; Bhoomi Madhu; Luca Paruzzo; Kecheng Han; Andre Kelly; Alexander Shestov; He N Xu; Alberto Carturan; Chaoting Zhou; Kevin R Amses; Amichay Afriat; Lev Litichevskiy; Jason Lin; Ezra Dubowitz; Neil Tangal; Jing Zhang; Alana McSween; Melody Tan; Federico Stella; Andrew Lee; Siena Nason; Xianxin Hua; Michael Schneider; Madeleine Sleeman; Yunlin Zhang; Giulia Gabrielli; Ziqi Yang; Raymone Pajarillo; Ruchi Patel; Guido Ghilardi; Vrutti Patel; Akshita Joshi; Shunzhou Jiang; Yanqing Jiang; Patrizia Porazzi; Julia C Tchou; Brian Keith; Mingyao Li; Elise Chong; Stephen J Schuster; Michael Milone; Joshua Rabinowitz; Roderick O’Connor; Christoph A Thaiss; Maayan Levy; Marco Ruella β-Hydroxybutyrate Enhances the Metabolic Fitness of CAR T Cells in Cancer , Cell, 189(6): 2026,1701-1716.e24

Landsburg DJ, Musoke N, Gentile C, Brooks TR, Nasta SD, Barta SK, Carter JS, Chong EA, Svoboda J, Schuster SJ, Thomas CJ, Tomasulo EB, Cook MR, Morrissette JJD, Caimi PF, Hill BT. Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma , Leukemia, 40(3): 2026,694-697

Jiang C, Hoover T, Baron J, Han X, Li B, Gao Y, Kim M, Hubbeling H, Chong EA, Carter J, Svoboda J, Schuster SJ, Landsburg DJ, Nasta SD, Plastaras J, LaRiviere M. Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma. , Int J Part Ther, 19: 2026,101304

Chong EA, Chong ER, Hwang WT, Jones M, Kennard K, Koch B, Lundberg R, Napier E, Nelson A, Ruella M, Susanibar-Adaniya S, Schuster S. A Phase II trial of epcoritamab prior to and after anti-CD19 CAR T cells for relapsed or refractory large B cell lymphomas , Blood, TBD(TBD): 2026

Carter J, Cheon HJ, Ma S, Tomasulo E, Cook M, Landsburg D, Svoboda J, Nasta SD, Thomas CJ, Ayers E, Nakhoda S, Rhodes J, D’Angelo C, Barta S, Ruella M, Brandstadter J, Schuster S, Andreadis C, Chong E. Real-world analysis of reduced dose polatuzumab vedotin-based regimens in the frontline setting in older or frail patients with large B-cell lymphoma (LBCL) , Blood, TBD(TBD): 2026

Tomasulo EB, Cook MR, Chong EA Balancing efficacy with toxicity: should tafasitamab-lenalidomide-R-CHOP be front of MIND for frontline large B cell lymphoma therapy? , AME Clinical Trials Review, TBD(TBD): 2026

Chong EA, Mehta K, Rhodes JM Follicular lymphoma: role of molecular disease characterization in diagnosis and prognosis , Hematology, TBD(TBD): 2026

Epstein-Peterson ZD, Lionel AC, Joseph A, Drill E, Atallah-Yunes SA, Brooks TR, Chong EA, Chong ER, Dela Cruz J, Frank MJ, Ip A, Iqbal M, Jacobson CA, Kamdar MK, Karmali R, Beyar-Katz O, Maddocks KJ, Matasar MJ, McLoughlin D, Merryman RW, Munoz JL, Navalekar R, Rhodes J, Riedell PA, Ryan CE, Salles G, Sauter CS, Sawalha Y, Sharma S, Shouval R, Shukla N, Therwhanger D, van Besien H, Varon B, Wang Y, Yamshon S, Zelenetz AD, Palomba ML, Jain P, Kumar A. Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis , Blood Adv, 9(21): 2025,5654-5662